In a major step toward digitizing regulatory workflows and strengthening Pakistan’s pharmaceutical export ecosystem, the Pakistan Single Window (PSW) has officially integrated the Drug Regulatory Authority of Pakistan’s (DRAP) key export-related services into its national digital platform. This integration marks a significant milestone in facilitating paperless, efficient, and secure pharmaceutical exports, especially to high-standard international markets like the European Union and the United States.
The newly launched PSW-DRAP Clearance Gateway introduces a one-window digital interface for five essential regulatory services critical to the pharmaceutical export process. These include entity and product registration, export permits, Certificates of Pharmaceutical Product (COPP), Good Manufacturing Practice (GMP) certifications, and Free Sale Certificates (FSC).
A significant feature of this integration is the digitally verifiable QR codes embedded on all certifications issued through the PSW-DRAP module. This functionality enables real-time authentication of documents, minimizes human error, and significantly reduces the risk of document forgery or counterfeiting—a long-standing concern in the international pharmaceutical trade.
By embedding traceability and transparency into the export process, the integration not only enhances regulatory compliance but also improves global confidence in Pakistani pharmaceutical products. This comes as an important development as Pakistan seeks to expand its pharma footprint in international markets.
The integration also signifies the completion of digital onboarding of all cross-border Licenses, Permits, Certificates, and Other Documents (LPCOs) related to pharmaceutical raw materials, packaging components, active ingredients, and finished drug products. This comprehensive digital coverage is expected to streamline the entire pharmaceutical supply chain, reducing paperwork, improving oversight, and cutting down on export clearance times.
According to official sources, the integration aligns with the World Health Organization’s (WHO) Global Digital Health Strategy, aiming to improve regulatory efficiency and ultimately contribute to better public health outcomes. The adoption of such tech-driven reforms demonstrates Pakistan’s growing commitment to digital governance in health and trade sectors.
To ensure effective implementation, several change management sessions have been held with DRAP officials, pharmaceutical manufacturers, and customs clearing agents, offering hands-on training and awareness about the new digital workflows. Currently in pilot mode, the services are expected to be fully rolled out nationwide by the end of May 2025, ensuring smooth adoption and operational readiness across the pharmaceutical export sector.
In support of the integration, the Ministry of Science and Technology has issued formal notifications to heads of all major scientific, regulatory, and academic institutions, mandating strict adherence to the new digital export procedures under the PSW platform.
The PSW-DRAP digital gateway will continue to evolve in response to DRAP’s emerging regulatory needs, enabling future enhancements and further consolidation of Pakistan’s pharmaceutical export documentation within a centralized, secure, and efficient digital system.
This initiative is a pivotal development in Pakistan’s journey toward digital transformation, solidifying the country’s ambition to create a globally competitive and technologically empowered pharma export industry.
